A Salmonella Typhimurium-Typhi Genomic Chimera: A Model to Study Vi Polysaccharide Capsule Function In Vivo
2011

Studying the Function of the Vi Polysaccharide Capsule in Salmonella

Sample size: 30 publication 10 minutes Evidence: high

Author Information

Author(s): Angela M. Jansen, Lindsay J. Hall, Simon Clare, David Goulding, Kathryn E. Holt, Andrew J. Grant, Piero Mastroeni, Gordon Dougan, Robert A. Kingsley

Primary Institution: The Wellcome Trust Sanger Institute

Hypothesis

Does the expression of the Vi polysaccharide capsule by Salmonella Typhimurium modulate the innate immune response during infection?

Conclusion

The Vi polysaccharide capsule alters the immune response to Salmonella infection, leading to reduced recruitment of certain immune cells.

Supporting Evidence

  • The Vi capsule was shown to reduce the recruitment of immune cells during infection.
  • Mice infected with the Vi-positive strain had fewer pro-inflammatory cytokines.
  • IL-10 levels were significantly higher in mice infected with the Vi-positive strain.
  • Vi expression was linked to altered immune cell populations in the spleen.
  • Colonization levels were similar between Vi-positive and Vi-negative strains.

Takeaway

The study shows that a special coating on Salmonella bacteria can change how the body's immune system reacts, making it harder for the body to fight the infection.

Methodology

The study involved creating a Salmonella chimera and testing its effects on immune responses in mice through various inoculation methods.

Limitations

The study primarily uses a mouse model, which may not fully replicate human responses to Salmonella infection.

Participant Demographics

C57BL/6 and 129/sv mice were used in the experiments.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1371/journal.ppat.1002131

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication